Foresite Capital Management II as of March 31, 2019
Portfolio Holdings for Foresite Capital Management II
Foresite Capital Management II holds 8 positions in its portfolio as reported in the March 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Aerie Pharmaceuticals | 35.9 | $80M | 1.7M | 47.50 | |
| Aimmune Therapeutics | 27.5 | $61M | 2.7M | 22.35 | |
| Insmed (INSM) | 12.1 | $27M | 919k | 29.07 | |
| Alder Biopharmaceuticals | 9.8 | $22M | 1.6M | 13.65 | |
| Epizyme | 8.3 | $18M | 1.5M | 12.39 | |
| Acceleron Pharma | 4.0 | $8.8M | 189k | 46.57 | |
| BioDelivery Sciences International | 1.7 | $3.8M | 717k | 5.30 | |
| Twist Bioscience Corp (TWST) | 0.8 | $1.7M | 73k | 23.18 |
